文献速递眼底病与葡萄膜炎

CFH基因风险变异与特发性多灶性脉络膜炎中凝血和补体因子水平升高的关联

Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis.
PubMed 文献 · JAMA Ophthalmol · 2023-01-01

这项多中心病例对照全基因组关联研究和血浆蛋白研究纳入荷兰6所大学的4437名队列1参与者和1344名队列2参与者,发现特发性多灶性脉络膜炎的主要关联位点位于CFH基因rs7535263(A等位基因OR 0.52,95%CI 0.41-0.64,P=9.3×10^-9),且与经典HLA等位基因无全基因组显著关联;蛋白组学分析87例患者显示rs7535263风险等位基因G与FHR蛋白及血小板活化和补体级联蛋白血浆浓度升高强相关。作者认为补体和凝血通路可能是治疗特发性多灶性脉络膜炎的关键靶点。

要点

  • 特发性多灶性脉络膜炎的主要GWAS关联位于CFH基因rs7535263,A等位基因OR 0.52(95%CI 0.41-0.64,P=9.3×10^-9)。
  • 与经典HLA等位基因无全基因组显著关联,领先经典等位基因HLA-A*31:01的P=.002。
  • rs7535263风险等位基因G与FHR-2等FHR蛋白及血小板活化、补体级联蛋白血浆浓度升高强相关(FHR-2似然比检验校正P=1.1×10^-3)。

核心结论

  • 结果提示CFH基因变异增加补体和凝血级联关键因子的全身浓度,从而赋予特发性多灶性脉络膜炎易感性。
  • 这些发现提示补体和凝血通路可能是治疗特发性多灶性脉络膜炎的关键靶点。

研究设计与样本

  • 这是一项病例对照全基因组关联研究和血浆蛋白研究,于2006年3月至2022年2月开展,涉及6所荷兰大学的多中心研究。
  • 队列1包括170例荷兰特发性多灶性脉络膜炎患者和4267名对照,共4437名参与者(平均[SD]年龄55[18]岁,女性2443名[55%])。
  • 队列2包括52例多灶性脉络膜炎患者和1292名对照,共1344名参与者(男性737名[55%])。
  • 未接受治疗的特发性多灶性脉络膜炎患者血浆样本接受靶向蛋白组学分析。
  • 特发性多灶性脉络膜炎根据标准化葡萄膜炎命名(SUN)工作组关于点状内层脉络膜病变和伴全葡萄膜炎的多灶性脉络膜炎指南诊断;数据分析于2021年7月至2022年10月进行。

主要发现

  • 主要GWAS关联定位到CFH基因并达全基因组显著性,领先变异为rs7535263的A等位基因(OR 0.52,95%CI 0.41-0.64,P=9.3×10^-9)。
  • 与经典HLA等位基因无全基因组显著关联,领先经典等位基因HLA-A*31:01的P=.002。
  • rs7535263的关联在52例病例和1292例对照的独立队列中显示一致效应方向(合并荟萃分析OR 0.58,95%CI 0.38-0.77,P=3.0×10^-8)。
  • 在87例患者的蛋白组学分析中,CFH基因rs7535263的风险等位基因G与FHR蛋白(如FHR-2,似然比检验校正P=1.1×10^-3)及参与血小板活化和补体级联的蛋白血浆浓度升高强相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Idiopathic multifocal choroiditis (MFC) is poorly understood, thereby hindering optimal treatment and monitoring of patients. OBJECTIVE: To identify the genes and pathways associated with idiopathic MFC. DESIGN, SETTING, AND PARTICIPANTS: This was a case-control genome-wide association study (GWAS) and protein study of blood plasma samples conducted from March 2006 to February 2022. This was a multicenter study involving 6 Dutch universities. Participants were grouped into 2 cohorts: cohort 1 consisted of Dutch patients with idiopathic MFC and controls, and cohort 2 consisted of patients with MFC and controls. Plasma samples from patients with idiopathic MFC who had not received treatment were subjected to targeted proteomics. Idiopathic MFC was diagnosed according to the Standardization of Uveitis Nomenclature (SUN) Working Group guidelines for punctate inner choroidopathy and multifocal choroiditis with panuveitis. Data were analyzed from July 2021 to October 2022. MAIN OUTCOMES AND MEASURES: Genetic variants associated with idiopathic MFC and risk variants associated with plasma protein concentrations in patients. RESULTS: This study included a total of 4437 participants in cohort 1 (170 [3.8%] Dutch patients with idiopathic MFC and 4267 [96.2%] controls; mean [SD] age, 55 [18] years; 2443 female [55%]) and 1344 participants in cohort 2 (52 [3.9%] patients with MFC and 1292 [96.1%] controls; 737 male [55%]). The primary GWAS association mapped to the CFH gene with genome-wide significance (lead variant the A allele of rs7535263; odds ratio [OR], 0.52; 95% CI, 0.41-0.64; P = 9.3 × 10-9). There was no genome-wide significant association with classical human leukocyte antigen (HLA) alleles (lead classical allele, HLA-A*31:01; P = .002). The association with rs7535263 showed consistent direction of effect in an independent cohort of 52 cases and 1292 control samples (combined meta-analysis OR, 0.58; 95% CI, 0.38-0.77; P = 3.0 × 10-8). In proteomic analysis of 87 patients, the risk allele G of rs7535263 in the CFH gene was strongly associated with increased plasma concentrations of factor H-related (FHR) proteins (eg, FHR-2, likelihood ratio test, adjusted P = 1.1 × 10-3) and proteins involved in platelet activation and the complement cascade. CONCLUSIONS AND RELEVANCE: Results suggest that CFH gene variants increase systemic concentrations of key factors of the complement and coagulation cascades, thereby conferring susceptibility to idiopathic MFC. These findings suggest that the complement and coagulation pathways may be key targets for the treatment of idiopathic MFC.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. de Groot EL, Ossewaarde-van Norel J, de Boer JH, et al. Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis. JAMA Ophthalmol. 2023. PMID: 37410486. doi:10.1001/jamaophthalmol.2023.2557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。